Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Treatment with the CB1R antagonist rimonabant rescues brain mitochondrial dysfunction via inhibition of intra-mitochondrial protein kinase A signalling in a mouse model of Rett syndrome

Autor: Urbinati, C., Cosentino, L., Valenti, D., De Rasmo, D., Signorile, A., Pellas, M., Vacca, R. A., De Filippis, B.

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=od______3686::38fb1460bc3ec52071f37ae85c1acd86
https://hdl.handle.net/11573/1672908

Oncogenic K-ras expression is associated with derangement of the cAMP/PKA pathway and forskolin-reversible alterations of mitochondrial dynamics and respiration.

Autor: Palorini, R¹, De Rasmo, D², Gaviraghi, M¹, Danna, L Sala¹, Signorile, A³, Cirulli, C¹, Chiaradonna, F¹, Alberghina, L¹, Papa, S²

Publikováno v: Oncogene. 1/17/2013, Vol. 32 Issue 3, p352-362. 11p.

Deciphering the Mitochondrial Tail of FoxO3A Code

Autor: Celestini, Tezil, T., Russo, L., Fasano, C., Forte, G., Grossi, V., Sanese, P., De Rasmo, D., Signorile, A., Gadaleta, R., Scialpi, N., Cocco, T. M., Terao, M., Garattini, E., Moschetta, A., Villani, G., Peserico, A., C. Simone.

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=od______3664::d0f50126936afac791571939ed03ab8a
http://hdl.handle.net/11575/121521

Pharmacological activation of Protein Phosphatase 2 A (PP2A) activity: A novel strategy to fight against human malignancies?

Autor: Carratù MR, Signorile A, De Rasmo D, Reale A, Vacca A.

Publikováno v: Current medicinal chemistry (2016).
info:cnr-pdr/source/autori:Carratù MR, Signorile A, De Rasmo D, Reale A, Vacca A./titolo:Pharmacological activation of Protein Phosphatase 2 A (PP2A) activity: A novel strategy to fight against human malignancies?/doi:/rivista:Current medicinal chemistry/anno:2016/pagina_da:/pagina_a:/intervallo_pagine:/volume

BACKGROUND: The serine-threonine protein phosphatase 2A (PP2A) regulates multiple cell signaling cascades and its inactivation by viral oncoproteins, mutation of specific structural subunits or upregulation of the cellular endogenous inhibitors may c

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=cnr_________::b804e1e0a25fb213a827991372081289
https://publications.cnr.it/doc/360167